Actively Recruiting
Study of CXCR4-Targeted PETCT Imaging to Diagnose and Locate ACTH-Dependent and Independent Cushings Syndrome
Led by Peking Union Medical College Hospital · Updated on 2026-01-20
160
Participants Needed
1
Research Sites
49 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating the use of CXCR4-targeted PETCT imaging with 68Ga-Pentixafor to improve the diagnosis of Cushings syndrome, focusing on differentiating between ACTH-dependent and ACTH-independent types. This prospective observational study aims to assess how well this imaging method works compared to conventional techniques and, when available, 68Ga-DOTATATE PETCT. The study is conducted by the Nuclear Medicine team at Peking Union Medical College Hospital, leveraging their expertise in neuroendocrine tumor imaging.
CONDITIONS
Brief Title
Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome
Research Team
Z
Zhaohui Zhu, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
